Cargando…

Efficacy evaluation of serum galectin-3 in hypertension complicated with diastolic dysfunction

Serum galectin-3 (Gal-3) in patients with hypertension complicated with diastolic dysfunction and its predictive value for efficacy were investigated. One hundred patients with hypertension complicated with diastolic dysfunction admitted to the First Affiliated Hospital of Jiamusi University from Ju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Tianwei, Li, Hongbin, Wang, Shuang, Chen, Weida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909668/ https://www.ncbi.nlm.nih.gov/pubmed/31853284 http://dx.doi.org/10.3892/etm.2019.8215

Ejemplares similares

Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction
por: Ansari, Uzair, et al.
Publicado: (2018)

Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2017)

Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Galectin-3 as an early marker of diastolic dysfunction in children with end-stage renal disease on regular hemodialysis
por: Elsadek, Akram, et al.
Publicado: (2022)

Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction
por: Voors, Adriaan A., et al.
Publicado: (2010)

The clinical usefulness of central hemodynamics to evaluate diastolic dysfunction in subjects without hypertension
por: Kim, GeeHee, et al.
Publicado: (2014)

Layer-specific systolic and diastolic strain in hypertensive patients with and without mild diastolic dysfunction
por: Sharif, Hisham, et al.
Publicado: (2018)

Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
por: Bertacchini, Fabio, et al.
Publicado: (2022)

Serum PINP, PIIINP, galectin-3, and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties
por: Lepojärvi, E. Samuli, et al.
Publicado: (2015)

Evaluation of right ventricular diastolic function, systolic function, and circulating galectin‐3 concentrations in dogs with pulmonary stenosis
por: Winter, Randolph L., et al.
Publicado: (2023)

P-wave dispersion and left ventricular diastolic dysfunction in hypertension
por: Ertem, Ahmet Göktuğ, et al.
Publicado: (2015)

Addition of Amlodipine or Valsartan for Improvement of Diastolic Dysfunction Associated with Hypertension
por: Oh, Jin Kyung, et al.
Publicado: (2020)

Early diastolic filling dynamics in diastolic dysfunction
por: King, Gerard J, et al.
Publicado: (2003)

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
por: He, Xin-Wei, et al.
Publicado: (2017)

Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Afshar, Majid, et al.
Publicado: (2012)

Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction
por: Perez, Vinicio A. de Jesus, et al.
Publicado: (2012)

Obesity and Hypertension in Association with Diastolic Dysfunction Could Reduce Exercise Capacity
por: Kim, JinShil, et al.
Publicado: (2016)

Sex-specific predictors of left ventricular diastolic dysfunction in untreated hypertension
por: Jaroch, Joanna, et al.
Publicado: (2016)

Predictive Modeling of Secondary Pulmonary Hypertension in Left Ventricular Diastolic Dysfunction
por: Harrod, Karlyn K., et al.
Publicado: (2021)

Prevalence and prognosis of left ventricular diastolic dysfunction in community hypertension patients
por: Zhou, Dan, et al.
Publicado: (2022)

Galectin-1 and Galectin-9 Concentration in Maternal Serum: Implications in Pregnancies Complicated with Preterm Prelabor Rupture of Membranes
por: Boroń, Dorota Grażyna, et al.
Publicado: (2022)

Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection
por: Liu, Kuan-Ting, et al.
Publicado: (2016)

Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
por: Karetnikova, Victoria, et al.
Publicado: (2016)

Association between Reduced Serum Zinc and Diastolic Dysfunction in Maintenance Hemodialysis Patients
por: Huang, Jiun-Chi, et al.
Publicado: (2021)

Serum Galectin-3 level, not Galectin-1, is associated with the clinical feature and outcome in patients with acute ischemic stroke
por: Dong, Han, et al.
Publicado: (2017)

Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
por: Lau, Emily S., et al.
Publicado: (2021)

Let's Look Right during Diastolic Dysfunction Evaluation?
por: Foppa, Murilo, et al.
Publicado: (2019)

Echocardiographic evaluation of diastolic function in the setting of pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2019)

Serum galectin-3 levels are decreased in schizophrenia
por: Kiliç, Faruk, et al.
Publicado: (2020)

Erratum: Obesity and Hypertension in Association with Diastolic Dysfunction Could Reduce Exercise Capacity
por: Kim, JinShil, et al.
Publicado: (2016)

Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge
por: Agrawal, Vineet, et al.
Publicado: (2019)

Serum galectin‐3 concentrations in patients with ankylosing spondylitis
por: Cao, Ming‐Yu, et al.
Publicado: (2019)

Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5
por: Hsu, Bang-Gee, et al.
Publicado: (2021)

Predictors of Diastolic-To-Wedge Gradient in Patients Evaluated for Pulmonary Hypertension
por: Brittain, Evan L., et al.
Publicado: (2013)

Managing Diastolic Dysfunction Perioperatively
por: Cios, Theodore J., et al.
Publicado: (2022)

UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension
por: Chen, Xu, et al.
Publicado: (2021)

Cardiovascular Autonomic Neuropathy Is an Independent Risk Factor for Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
por: Jin, Jiewen, et al.
Publicado: (2017)

Serum aldosterone effect on left ventricular structure and diastolic function in essential hypertension
por: Al‐Hashedi, Ekhlas Mahmoud, et al.
Publicado: (2022)

Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects
por: Galderisi, Maurizio
Publicado: (2005)

Serum Uric Acid Is Associated with the Progression of Left Ventricular Diastolic Dysfunction in Apparently Healthy Subjects
por: Yang, Chen Die, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s76lnc8fiogjnvt4a4tptpp84i